نتائج البحث - Su Jeong Park

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1
    The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents

    The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents حسب Su Jeong Park, In‐ho Song, Gyu Seong Yeom, Satish Balasaheb Nimse

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Current status and future direction of metallic and polymeric materials for advanced vascular stents

    Current status and future direction of metallic and polymeric materials for advanced vascular stents حسب Seung Hyuk Im, Dam Hyeok Im, Su Jeong Park, Youngmee Jung, Dong‐Hwee Kim, Soo Hyun Kim

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial حسب Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: